Uncoupled Cardiac Nitric Oxide Synthase Mediates Diastolic Dysfunction
Author(s) -
Gad A. Silberman,
Tai-Hwang M. Fan,
Hong Liu,
Zhe Jiao,
Hong Xiao,
Joshua D. Lovelock,
Beth M. Boulden,
Julian D. Widder,
Scott Fredd,
Kenneth E. Bernstein,
Beata M. Wolska,
Sergey Dikalov,
David G. Harrison,
Samuel C. Dudley
Publication year - 2010
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.109.883777
Subject(s) - phospholamban , diastole , medicine , endocrinology , nitric oxide synthase , heart failure , tetrahydrobiopterin , cardiology , cardiac output , ejection fraction , nitric oxide , blood pressure
Heart failure with preserved ejection fraction is 1 consequence of hypertension and is caused by impaired cardiac diastolic relaxation. Nitric oxide (NO) is a known modulator of cardiac relaxation. Hypertension can lead to a reduction in vascular NO, in part because NO synthase (NOS) becomes uncoupled when oxidative depletion of its cofactor tetrahydrobiopterin (BH(4)) occurs. Similar events may occur in the heart that lead to uncoupled NOS and diastolic dysfunction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom